Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
A Phase 2, Randomized, Placebo-Controlled, Double-Masked, Multicenter Safety and Efficacy Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Acuity Due to Age-Related Cataract
The purpose of this study is to determine the safety and efficacy of C-KAD Ophthalmic Solution in improving visual acuity relative to placebo in patients with age-related cataract
An Open-Label Study of the Effect of C-KAD Ophthalmic Solution on Asteroid Hyalosis
To determine the safety and initial efficacy of C-KAD ophthalmic solution in patients with asteroid hyalosis
A Randomized, Placebo-Controlled, Single-Masked, Dose-Ranging Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataracts
This study will evaluate the safety and efficacy of three doses of C-KAD Ophthalmic Solution in patients with loss of visual function due to age-related nuclear cataract
100 Clinical Results associated with Chakshu Research, Inc.
0 Patents (Medical) associated with Chakshu Research, Inc.
100 Deals associated with Chakshu Research, Inc.
100 Translational Medicine associated with Chakshu Research, Inc.